8 Aug 2019
Forbes
“In this tech-governed era that has long been proclaimed the era of artificial intelligence (AI), one of the most promising sectors for early adoption is health care. So why is the adoption rate of AI in health care so slow? And why is it that technology experts, who typically come from either startups or big tech giants, are the driving force of innovation, rather than traditional leaders in the health care field?”
The Forbes article, discusses strategies for integrating AI into clinical workflows, emphasizing FDNA’s Face2Gene technology. Face2Gene utilizes advanced AI to analyze facial features, facilitating the expedited diagnosis of rare genetic disorders with high accuracy. The article highlights the importance of seamless integration of AI decision support tools into existing clinical workflows to gain acceptance from healthcare professionals. FDNA’s success with Face2Gene demonstrates how AI can enhance diagnostic processes, improve patient outcomes, and streamline operations.
